Schanz Nils

SEC Form 4 insider
EVP Product & Technology · Cerence Inc. ($CRNC)
1 thesis · first seen Oct 9, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$CRNCSEC Form 4bearish
Sold 52,439 @ $8.00 avg · $419,512 · 2026-10-07

Form 4: Schanz Nils sold CRNC

Schanz Nils (EVP Product & Technology at Cerence Inc.) reported an open-market sale of 52,439 shares of CRNC at an average $8.00, roughly $419,512, in a Form 4 filed 2026-10-09.

View filing on SEC.gov →

End of results.